Search | IOVS | ARVO Journals

iovs

Issues
Topics
For Authors
About
- Editorial Board

Journals Home

MANAGE ALERTS

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board

Narrow View

NARROW

Content Type

Meeting Abstract (9)
Journal Articles (2)

Journal

Investigative Ophthalmology & Visual Science (11)

Article Type

ARVO Annual Meeting Abstract (9)
Anatomy and Pathology/Oncology (1)
Retinal Cell Biology (1)

Topics

Eye Anatomy and Disorders (2)
Immunology and Microbiology (2)
Retina (2)
Eye Injuries / Ocular Trauma (1)
Genetics (1)
Retinal Cell Biology (1)
Spatial Vision (1)
Visual Psychophysics and Physiological Optics (1)

Tags

complement pathway, alternative (2)
familial hypercholesterolemia (2)
family history (2)
mice (2)
age-related macular degeneration (1)
angiogenesis (1)
biological response modifiers (1)
choroidal neovascularization (1)
eye injuries (1)
lasers (1)

Specify Date Range

From: To: Apply

Showing 1 – 11 of 11

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2017

Inhibiting complement C3 activation by gene therapy reduces glaucoma progression

Alejandra Bosco; Sarah Anderson; Kevin T Breen; Cesar O Romero; Michael R Steele; Vince A Chiodo; Sanford L Boye; William W Hauswirth; Stephen Tomlinson; Monica L Vetter

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2957. doi:

ARVO Annual Meeting Abstract June 2017

Delivery of CR2-fH using AAV vector therapy as a treatment strategy in mouse model of choroidal neovascularization.

Baerbel Rohrer; Gloriane Schnabolk; Balasubramaniam Annamalai; Nathaniel Parsons; Elisabeth Obert; Alfred S Lewin; Stephen Tomlinson

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3388. doi:

ARVO Annual Meeting Abstract September 2016

The complement system is dual-hatted, acting in both damage and repair processes in the murine model of choroidal neovascularization.

Baerbel Rohrer; Nate Parsons; Gloriane Schnabolk; Steven Tomlinson

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2123. doi:

Retinal Cell Biology April 2016

A Targeted Inhibitor of the Alternative Complement Pathway Accelerates Recovery From Smoke-Induced Ocular Injury

PDF

Alex Woodell; Bryan W. Jones; Tucker Williamson; Gloriane Schnabolk; Stephen Tomlinson; Carl Atkinson; Bärbel Rohrer
TAGS: familial hypercholesterolemia, family history, smoke, eye injuries, complement pathway, alternative, recovery of function, mice, biological response modifiers
Invest. Ophthalmol. Vis. Sci.. 2016; 57(4):1728-1737. doi: https://doi.org/10.1167/iovs.15-18471

ARVO Annual Meeting Abstract June 2015

Inhibition of the alternative pathway of complement accelerates recovery from smoke-induced functional and morphological ocular injury

Baerbel Rohrer; Alex Woodell; Sarah Casey; Tucker Williamson; Bryan W Jones; Stephen Tomlinson; Carl Atkinson

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2288. doi:

ARVO Annual Meeting Abstract June 2015

New insights on complement inhibitor CD59 in mouse laser-induced choroidal neovascularization: reduced expression after injury and targeted delivery for protein replacement

Gloriane Schnabolk; Mausumi Bandyopadhyay; Stephen Tomlinson; Baerbel Rohrer

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5459. doi:

ARVO Annual Meeting Abstract April 2010

Multifactorial Contributions of Complement Initiation Pathways to Mouse Laser-Induced Choroidal Neovascularization

B. Rohrer; B. Coughlin; Q. Long; G. S. Gilkeson; S. Tomlinson; K. Takahashi; V. M. Holers

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):3501. doi:

Anatomy and Pathology/Oncology July 2009

A Targeted Inhibitor of the Alternative Complement Pathway Reduces Angiogenesis in a Mouse Model of Age-Related Macular Degeneration

PDF

Bärbel Rohrer; Qin Long; Beth Coughlin; R. Brooks Wilson; Yuxiang Huang; Fei Qiao; Peter H. Tang; Kannan Kunchithapautham; Gary S. Gilkeson; Stephen Tomlinson
TAGS: age-related macular degeneration, angiogenesis, choroidal neovascularization, complement pathway, alternative, familial hypercholesterolemia, family history, mice, lasers, vascular endothelial growth factor a
Invest. Ophthalmol. Vis. Sci.. 2009; 50(7):3056-3064. doi: https://doi.org/10.1167/iovs.08-2222

ARVO Annual Meeting Abstract April 2009

A Dual-Hit Hypothesis in Retinal Pigmented Epithelial Cell Dysfunction: Oxidative Stress Renders Cells Susceptible to Complement-Mediated Injury

B. Rohrer; K. Kunchithapautham; B. Renner; M. Bandyopadhyay; N. Perron; V. P. Ferreira; M. K. Pangburn; Z. Ablonczy; S. Tomlinson; J. M. Thurman

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3521. doi:

ARVO Annual Meeting Abstract May 2008

Eliminating Alternative Complement Pathway Signaling Reduces CNV in a Mouse Model of Wet AMD

B. Rohrer; Q. Long; R. B. Wilson; Y. Huang; F. Qiao; P. H. Tang; K. Kunchithapautham; G. S. Gilkeson; S. M. Tomlinson

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1371. doi:

ARVO Annual Meeting Abstract May 2007

Light-Damage as a Model to Study Complement-Mediated Photoreceptor Degeneration

B. Rohrer; Z. Ablonczy; S. Tomlinson; G. Gilkeson

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):2497. doi:

« Previous

Advertisement

Follow @ARVOiovs

IOVS Home
Issues
Topics
For Authors
About
- Editorial Board

Online ISSN: 1552-5783

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2015 Association for Research in Vision and Ophthalmology.

Access Provided By:
MIT Libraries

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept